243 related articles for article (PubMed ID: 8975946)
1. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.
Niederau C; Borchard F; Lüthen R; Niederau M
Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946
[TBL] [Abstract][Full Text] [Related]
2. Bile-pancreatic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation.
Samuel I; Joehl RJ
Am J Surg; 1996 Jan; 171(1):207-11. PubMed ID: 8554143
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction.
Murayama KM; Samuel I; Toriumi Y; Solomon TE; Turkelson CM; Joehl RJ
J Surg Res; 1993 Feb; 54(2):126-31. PubMed ID: 7683071
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Surg Res; 1993 Feb; 54(2):132-5. PubMed ID: 8479170
[TBL] [Abstract][Full Text] [Related]
5. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
6. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
[TBL] [Abstract][Full Text] [Related]
7. The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum.
Larsen F; Schlarman D; Andrus CC; Kaminski DL
Pancreas; 1991 May; 6(3):291-7. PubMed ID: 1713673
[TBL] [Abstract][Full Text] [Related]
8. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
10. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat.
Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I
Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474
[TBL] [Abstract][Full Text] [Related]
12. CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis.
Samuel I; Zaheer S; Nelson JJ; Yorek MA; Zaheer A
Pancreatology; 2004; 4(1):49-56. PubMed ID: 14988658
[TBL] [Abstract][Full Text] [Related]
13. Acute experimental pancreatitis--morphological evidence for the development of a multiple organ failure syndrome.
Vasilescu C; Taşcă C
Rom J Morphol Embryol; 1991; 37(1-2):25-9. PubMed ID: 1801975
[TBL] [Abstract][Full Text] [Related]
14. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
[TBL] [Abstract][Full Text] [Related]
16. Receptor strategies in pancreatitis.
Grendell JH
Yale J Biol Med; 1992; 65(5):431-6; discussion 437-40. PubMed ID: 1340060
[TBL] [Abstract][Full Text] [Related]
17. Enzyme load in pancreatic acinar cells is increased in the early stages of acute pancreatitis induced by duct obstruction in rats.
Uruñuela A; Manso MA; Ma Pinto R; Orfao A; De Dios I
Clin Sci (Lond); 2000 Feb; 98(2):143-50. PubMed ID: 10657268
[TBL] [Abstract][Full Text] [Related]
18. Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats.
Takács T; Czakó L; Jármay K; Hegyi P; Pozsár J; Marosi E; Pap A; Lonovics J
Acta Med Hung; 1994; 50(1-2):117-30. PubMed ID: 7543670
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats.
Tomita H; Miyasaka K; Jimi A; Mishima Y; Funakoshi A
Pancreas; 1994 Sep; 9(5):638-45. PubMed ID: 7809019
[TBL] [Abstract][Full Text] [Related]
20. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
